These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19455425)

  • 21. HIV, cognition and women.
    Maki PM; Martin-Thormeyer E
    Neuropsychol Rev; 2009 Jun; 19(2):204-14. PubMed ID: 19430907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocognitive assessment in the diagnosis of HIV-associated neurocognitive disorders.
    Robertson K; Yosief S
    Semin Neurol; 2014 Feb; 34(1):21-6. PubMed ID: 24715485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concordance Between Self-Report and Performance-Based Measures of Everyday Functioning in HIV-Associated Neurocognitive Disorders.
    Shirazi TN; Summers AC; Smith BR; Steinbach SR; Kapetanovic S; Nath A; Snow J
    AIDS Behav; 2017 Jul; 21(7):2124-2134. PubMed ID: 28108876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND).
    Morgan EE; Woods SP; Smith C; Weber E; Scott JC; Grant I;
    AIDS Behav; 2012 Nov; 16(8):2279-85. PubMed ID: 22677976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders.
    Cherner M; Cysique L; Heaton RK; Marcotte TD; Ellis RJ; Masliah E; Grant I;
    J Neurovirol; 2007; 13(1):23-8. PubMed ID: 17454445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychological impairment-associated visual field deficits in HIV infection. HNRC Group. HIV Neurobehavioral Research Center.
    Plummer DJ; Marcotte TD; Sample PA; Wolfson T; Heaton RK; Grant I; Freeman WR
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):435-42. PubMed ID: 9950603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroimaging of HIV-associated neurocognitive disorders (HAND).
    Ances BM; Hammoud DA
    Curr Opin HIV AIDS; 2014 Nov; 9(6):545-51. PubMed ID: 25250553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-associated cognitive disorders in perinatally infected children and adolescents: a novel composite cognitive domains score.
    Phillips NJ; Hoare J; Stein DJ; Myer L; Zar HJ; Thomas KGF
    AIDS Care; 2018; 30(sup1):8-16. PubMed ID: 29681168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive reserve during neuropsychological performance in HIV intravenous drug users.
    Vázquez-Justo E; Blanco AP; Vergara-Moragues E; Gestoso CG; Pérez-García M
    Appl Neuropsychol Adult; 2014; 21(4):288-96. PubMed ID: 25265310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
    Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
    J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders.
    Costaggiu D; Pinna E; Serchisu L; Barcellona D; Piano P; Ortu F; Marongiu F; Mandas A
    AIDS Care; 2021 Mar; 33(3):357-363. PubMed ID: 32183560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HIV associated neurocognitive disorders].
    Bragança M; Palha A
    Actas Esp Psiquiatr; 2011; 39(6):374-83. PubMed ID: 22127910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Special section of Neuropsychology Review on HIV/NeuroAIDS.
    Sullivan EV
    Neuropsychol Rev; 2009 Jun; 19(2):143. PubMed ID: 19466594
    [No Abstract]   [Full Text] [Related]  

  • 35. Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting.
    Yechoor N; Towe SL; Robertson KR; Westreich D; Nakasujja N; Meade CS
    J Neurovirol; 2016 Dec; 22(6):808-815. PubMed ID: 27245592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurocognitive symptoms and impairment in an HIV community clinic.
    Kim DH; Jewison DL; Milner GR; Rourke SB; Gill MJ; Power C
    Can J Neurol Sci; 2001 Aug; 28(3):228-31. PubMed ID: 11513341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effects of Age and HIV on Neuropsychological Performance.
    Valcour V; Paul R; Neuhaus J; Shikuma C
    J Int Neuropsychol Soc; 2011 Jan; 17(1):190-5. PubMed ID: 21144102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive impairment in HIV infection.
    Krikorian R; Wrobel AJ
    AIDS; 1991 Dec; 5(12):1501-7. PubMed ID: 1814332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children.
    Boivin MJ; Green SD; Davies AG; Giordani B; Mokili JK; Cutting WA
    Health Psychol; 1995 Jan; 14(1):13-21. PubMed ID: 7737068
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.